Region
Featured experience
Guotai Junan merger with Haitong and concurrent placement of shares
We advised Guotai Junan Securities on the transaction, creating the largest securities company in China
Chagee $411.2 million IPO
We advised Chagee on its IPO and Nasdaq listing
Tencent €1.16 billion investment in new Ubisoft subsidiary
We are advising Tencent on the transaction
iQIYI $350 million convertible notes offering and concurrent private repurchases
We advised iQIYI on the transactions
Morrison Express Worldwide acquisition by SG Holdings
We are advising Morrison Express Holdings as the seller
Ascentage Pharma $126.4 million IPO
The IPO is the first life sciences U.S. IPO of 2025 and the first life sciences company listed on the HKEX to complete a U.S…
ASMedia Technology $390 million acquisition of Techpoint
We are advising ASMedia on the transaction
Trustar Capital participation in proposed acquisition of Energy Monster
We advised Trustar Capital as a consortium member
BrainAurora Medical Technology HK$583 million IPO
We advised BrainAurora on its IPO and HKEX listing
Laekna HK$236 million placement of shares
We advised Laekna on the placement of new shares
Pony AI $413 million IPO
We advised Pony AI on its IPO, concurrent private placements and Nasdaq listing
Horizon Robotics HK$5.41 billion IPO
We advised Horizon Robotics on its IPO and HKEX listing
UP Fintech Holding $110 million follow-on offering
We advised UP Fintech on its SEC-registered offering
CK Hutchison Holdings $1 billion notes offering
We advised CK Hutchison Holdings on the investment-grade notes offering